Morgan Stanley Reaffirms Their Buy Rating on Meituan (MPNGF)
Morgan Stanley analyst maintained a Buy rating on Meituan on November 30 and set a price target of HK$120.00.
TipRanks Cyber Monday Sale
- Claim 60% off TipRanks Premium for data-backed insights and research tools you need to invest with confidence.
- Subscribe to TipRanks' Smart Investor Picks and see our data in action through our high-performing model portfolio - now also 60% off
In addition to Morgan Stanley, Meituan also received a Buy from DBS’s Andy Yu CFA in a report issued on December 1. However, on the same day, Barclays maintained a Sell rating on Meituan (Other OTC: MPNGF).
Based on Meituan’s latest earnings release for the quarter ending June 30, the company reported a quarterly revenue of HK$91.84 billion and a net profit of HK$365.3 million. In comparison, last year the company earned a revenue of HK$82.25 billion and had a net profit of HK$11.35 billion
Read More on MPNGF:
Disclaimer & DisclosureReport an Issue
- Meituan downgraded to Hold from Buy at Benchmark
- Meituan’s Strategic Positioning and Long-term Growth Potential Justify Buy Rating
- Meituan Dianping Faces Challenges Amidst Competitive Market
- Meituan Reports Revenue Growth Amidst Operating Losses in Q3 2025
- Meituan Schedules Board Meeting to Review Q3 2025 Financial Results
This article contains syndicated content. We have not reviewed, approved, or endorsed the content, and may receive compensation for placement of the content on this site. For more information please view the Barchart Disclosure Policy here.
This section contains press releases and other materials from third parties (including paid content). The Globe and Mail has not reviewed this content. Please see disclaimer.